Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Miles

Showing results (451-460 of 501) with videos related to

Pageof 51
Sort By:
Blood Advances|October 1, 2020
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphomaPaola Ghione, Promie Faruque, Neha Mehta-Shah, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2023
A Population-Based Family Case-Control Study of Sun Exposure and Follicular Lymphoma RiskMichael K Odutola, Marina T van Leeuwen, Fiona Bruinsma, et al.
Ejhaem|July 18, 2022
Alcohol and tobacco use and risk of multiple myeloma: A case-control studySimon Cheah, Julie K Bassett, Fiona J Bruinsma, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serumJennifer A Westwood, William K Murray, Melanie Trivett, et al.
Journal of Medicinal Chemistry|May 23, 2025
Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase InhibitorsCorinne N Foley, Shiwei Qu, Srinivas Reddy Paladugu, et al.
Scientific Reports|March 9, 2018
Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myelomaNicholas A Gherardin, Liyen Loh, Lorenztino Admojo, et al.
Plastic and Reconstructive Surgery|February 27, 2024
American Association of Plastic Surgeons Consensus on Breast Implant-Associated Anaplastic Large-Cell LymphomaMark W Clemens, Terence M Myckatyn, Arianna Di Napoli, et al.
Cancer Epidemiology|September 4, 2022
Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control studyMichael K Odutola, Marina T van Leeuwen, Jennifer Turner, et al.
Internal Medicine Journal|August 8, 2017
Bisphosphonate guidelines for treatment and prevention of myeloma bone diseaseOi Lin Lee, Noemi Horvath, Cindy Lee, et al.
Journal of Medicinal Chemistry|January 5, 2021
Discovery of Potent and Selective Methylenephosphonic Acid CD73 InhibitorsEhesan U Sharif, Jaroslaw Kalisiak, Kenneth V Lawson, et al.
Pageof 51

Showing results (451-460 of 501) with videos related to

Sort By:
Pageof 51
Blood Advances|October 1, 2020
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphomaPaola Ghione, Promie Faruque, Neha Mehta-Shah, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2023
A Population-Based Family Case-Control Study of Sun Exposure and Follicular Lymphoma RiskMichael K Odutola, Marina T van Leeuwen, Fiona Bruinsma, et al.
Ejhaem|July 18, 2022
Alcohol and tobacco use and risk of multiple myeloma: A case-control studySimon Cheah, Julie K Bassett, Fiona J Bruinsma, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serumJennifer A Westwood, William K Murray, Melanie Trivett, et al.
Journal of Medicinal Chemistry|May 23, 2025
Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase InhibitorsCorinne N Foley, Shiwei Qu, Srinivas Reddy Paladugu, et al.
Scientific Reports|March 9, 2018
Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myelomaNicholas A Gherardin, Liyen Loh, Lorenztino Admojo, et al.
Plastic and Reconstructive Surgery|February 27, 2024
American Association of Plastic Surgeons Consensus on Breast Implant-Associated Anaplastic Large-Cell LymphomaMark W Clemens, Terence M Myckatyn, Arianna Di Napoli, et al.
Cancer Epidemiology|September 4, 2022
Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control studyMichael K Odutola, Marina T van Leeuwen, Jennifer Turner, et al.
Internal Medicine Journal|August 8, 2017
Bisphosphonate guidelines for treatment and prevention of myeloma bone diseaseOi Lin Lee, Noemi Horvath, Cindy Lee, et al.
Journal of Medicinal Chemistry|January 5, 2021
Discovery of Potent and Selective Methylenephosphonic Acid CD73 InhibitorsEhesan U Sharif, Jaroslaw Kalisiak, Kenneth V Lawson, et al.
Pageof 51